أعرض في EDS

Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort

التفاصيل البيبلوغرافية
العنوان: Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort
المؤلفون: Yago Nieto, Zixi Yang, Ben C. Valdez, Suprateek Kundu, Roland Bassett, Melissa Barnett, Qaiser Bashir, Jeremy Ramdial, Neeraj Y. Saini, Samer A. Srour, Jin Seon Im, Partow Kebriaei, Uday R. Popat, Alison M. Gulbis, Rita Cool, Terri Lynn Shigle, Whitney Dale Wallis, Jason Yeh, Ruby Delgado, Sofia Qureshi, Hans C. Lee, Elisabet Manasanch, Robert Z. Orlowski, Sheeba K. Thomas, Elizabeth J. Shpall, Borje S. Andersson, Muzaffar H. Qazilbash
المصدر: Transplantation and Cellular Therapy. 29:S31-S32
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
تدمد: 2666-6367
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::80858ea262e69e657d061b4d73be9af6
https://doi.org/10.1016/s2666-6367(23)00107-0
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........80858ea262e69e657d061b4d73be9af6
قاعدة البيانات: OpenAIRE
الوصف
تدمد:26666367